e-learning
resources
Barcelona 2013
Tuesday, 10.09.2013
Systemic therapy of lung cancer and quality of life
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Anticancer chemotherapy combined with anti-tuberculosis treatment: A systematic review
A. Christopoulos, I. Katsarou, I. Christopoulos (Athens, Zakynthos, Greece)
Source:
Annual Congress 2013 –Systemic therapy of lung cancer and quality of life
Session:
Systemic therapy of lung cancer and quality of life
Session type:
Thematic Poster Session
Number:
4490
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Christopoulos, I. Katsarou, I. Christopoulos (Athens, Zakynthos, Greece). Anticancer chemotherapy combined with anti-tuberculosis treatment: A systematic review. Eur Respir J 2013; 42: Suppl. 57, 4490
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Pulmonary tuberculosis and lung cancer: A complex interaction
Source: International Congress 2016 – The best clinical approach to lung diseases
Year: 2016
Active TB in cancer patients: A missed screening opportunity?
Source: International Congress 2015 – Screening strategies in TB
Year: 2015
Lung cancer and lung tuberculosis: Our results of treatment in the combined lung disease
Source: International Congress 2016 – Surgical strategy for complex diseases
Year: 2016
Latent tuberculosis infection and the risk of cancer: A nationwide population-based study
Source: International Congress 2015 – Epidemiology of TB: deaths, co-morbidities, migration and children
Year: 2015
Progress of treatment delayed testicular tuberculosis: One case
Source: Annual Congress 2013 –Tuberculosis: clinical aspects
Year: 2013
Chemotherapy beyond 3rd line in NSCLC – A retrospective analysis
Source: International Congress 2015 – Lung cancer therapy: clinical trials
Year: 2015
The association of lung cancer with active pulmonary tuberculosis.
Source: International Congress 2014 – Clinical problems in acute and chronic lung diseases
Year: 2014
Treatment of pulmonary carcinoid: Are there new options?
Source: International Congress 2014 – Advances in diagnosis and therapy of thoracic tumours
Year: 2014
Miliary disease of the lung: What is your diagnosis?
Source: Annual Congress 2013 –Morphologic imaging
Year: 2013
Immuno-allergic reactions to antituberculosis treatment
Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management II
Year: 2013
Efficacy of preoperative comprehensive pulmonary rehabilitation in patients with lung cancer
Source: International Congress 2016 – New insights into pulmonary rehabilitation for chronic lung diseases
Year: 2016
Pulmonary function during lung cancer therapy: A retrospective analysis of patients treated with monotherapy or multimodal treatments
Source: International Congress 2016 – Clinical aspects of lung cancer
Year: 2016
Does every necrotizing granulomatous inflammation at NSCLC resection materials require treatment?
Source: International Congress 2016 – Treatment management options and costs: vitamin D, Matrix metalloproteinases (MMPs), nutrition, and human genetics
Year: 2016
Gene therapy with DDMC-p53 with or without cisplatin and microwave ablation. A future concept for local treatment in lung cancer
Source: International Congress 2015 – Diagnosis and therapy of lung cancer
Year: 2015
The rate of curative intended therapy against recurrent lung cancer before and after introduction of a CT-based follow-up program
Source: Annual Congress 2013 –Quality management in thoracic oncology
Year: 2013
Interventional management and outcome of lung cancer and cardiac disease. Meta-analytic review
Source: International Congress 2015 – Surgery and lung cancer: results and complications
Year: 2015
Maintenance therapy with pemetrexed in non-small-cell lung cancer: Impact on survival
Source: International Congress 2015 – Lung cancer therapy: clinical trials
Year: 2015
Lung cancer in women: What are particularities?
Source: International Congress 2014 – The epidemiology of respiratory infections and lung cancer
Year: 2014
Metronomic chemotherapy in human lung cancer: Mathematical modeling for an optimal schedule
Source: International Congress 2015 – Lung cancer therapy: clinical trials
Year: 2015
Lung cancer after lymphoma: Disease characteristics, detection methods and clinical outcome
Source: Annual Congress 2013 –Other thoracic tumours, particular circumstances and rare cases
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept